ASX to soar after US says no to tapering

US Markets, Aussie dollar and commodities rocket higher after US Federal Reserve declines to cut back quantitative easing

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P / ASX 200 Index (Index: ^AXJO) (ASX:XJO) is set to soar on Thursday, after the US Federal Open Market Committee (FOMC) surprised the markets by refraining from reducing its bond buying program.

The US S&P 500 soared to a record high, rising 1.2% to 1,725.52, while the Dow Jones Industrial Average rose 1% to 15,676.94. The ASX SPI Futures is indicating a 1.2% rise in early morning trade, while the Australian dollar rocketed past 95 US cents.

The FOMC said it needed to see more evidence of lasting improvement in the US economy and warning that an increase in interest rates threatened to stall the expansion. Chairman Ben Bernanke said, "Conditions in the job market today are still far from what all of us would like to see."

Growth forecasts for this year and next have been cut, suggesting the US economy is still struggling to recover. Mr Bernanke suggested the US Federal Reserve could move to taper its quantitative easing program later this year, if the economy shows further signs of improving.

Spot gold prices jumped US$55.61 to US$1,366 an ounce, while oil rose more than 2.5%. That should see a strong performance from Australia's gold producers, including Newcrest Mining (ASX: NCM), Kingsgate Consolidated (ASX: KCN), Regis Resources (ASX: RRL), and Beadell Resources (ASX: BDR). The bad news is that companies exposed to the US economy are likely to have to wait longer to see higher levels of growth. Markets around the globe will see increased levels of volatility as they try and work out whether the FOMC will begin to reduce its bond buying program in the coming months, or much later.

Foolish takeaway

Foolish investors will know that no matter what the US central bank decides to do, the focus remains of investing in great companies which will still be going strong for many years to come.

Interested in our #1 dividend-paying stock? Discover The Motley Fool's favourite income idea for 2013-2014 in our brand-new, FREE research report, including a full investment analysis! Simply click here for your FREE copy of "The Motley Fool's Top Dividend Stock for 2013-2014."

More reading


Motley Fool writer/analyst Mike King owns shares in Kingsgate Consolidated.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »